CardioGenics Inc, Product Pipeline Analysis, 2017 Update: Ken Research
CardioGenics Inc-Product Pipeline Analysis, 2017 Update

CardioGenics Inc-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME181757PD
  • |
  • Pages: 26
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company provides products such as immunoassay tests, QL care analyzer, and paramagnetic beads. Its QL care analyzer is a portable and automated point of care immune analyzer. CardioGenics provides immunoassay tests such as plasminogen activator inhibitor type-1 test, heart failure genomics risk test, heart failure risk stratification test, and troponin I test. The company's immunoassay tests are used to detect cardiac markers. It also develops a novel proprietary and patent-protected method to control the delivery of compounds to a chemical reaction automating the trigger. CardioGenics is headquartered in Mississauga, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company CardioGenics Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

CardioGenics Inc Company Overview 4

CardioGenics Inc Company Snapshot 4

CardioGenics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

CardioGenics Inc-Pipeline Analysis Overview 7

CardioGenics Inc-Key Facts 7

CardioGenics Inc-Major Products and Services 8

CardioGenics Inc Pipeline Products by Development Stage 9

CardioGenics Inc Pipeline Products Overview 11

Heart Failure Genomics Risk Test 11

Heart Failure Genomics Risk Test Product Overview 11

Heart Failure Risk Stratification Test 12

Heart Failure Risk Stratification Test Product Overview 12

Plasminogen Activator Inhibitor Type-1 Test 13

Plasminogen Activator Inhibitor Type-1 Test Product Overview 13

QL Care Analyzer 14

QL Care Analyzer Product Overview 14

Troponin-I Test 15

Troponin-I Test Product Overview 15

CardioGenics Inc-Key Competitors 16

CardioGenics Inc-Key Employees 17

CardioGenics Inc-Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

CardioGenics Inc, Recent Developments 19

Aug 25, 2015: CardioGenics Enters Into Manufacturing Agreement With Ontario-Based Plasticap 19

Feb 17, 2015: USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application 19

Aug 21, 2013: CardioGenics Announces Commencement of Beta-Site Testing 19

Jun 05, 2013: CardioGenics Gets IRB Approval For Beta-Site Testing 20

Apr 03, 2012: CardioGenics Announces Agreements with INO to Manufacture QL Care Analyzers 21

Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For QL Care Analyzer 21

Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For Troponin-I cardiovascular test 21

Jun 29, 2011: CardioGenics Receives US Patent For QL Care Analyzer Core Technology 21

Feb 22, 2011: CardioGenics Receives Canadian Patent For QL Care Analyzer Core Technology 22

Feb 03, 2011: CardioGenics To File For 510(k) Clearance With FDA By Fourth Quarter Of 2011 For QL Care Analyzer 22

Appendix 23

Methodology 23

About GlobalData 25

Contact Us 25

Disclaimer 25

List of Figures

CardioGenics Inc Pipeline Products by Equipment Type 5

CardioGenics Inc Pipeline Products by Development Stage 9

List of Tables

CardioGenics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

CardioGenics Inc Pipeline Products by Equipment Type 5

CardioGenics Inc Pipeline Products by Indication 6

CardioGenics Inc, Key Facts 7

CardioGenics Inc, Major Products and Services 8

CardioGenics Inc Number of Pipeline Products by Development Stage 9

CardioGenics Inc Pipeline Products Summary by Development Stage 10

Heart Failure Genomics Risk Test-Product Status 11

Heart Failure Genomics Risk Test-Product Description 11

Heart Failure Risk Stratification Test-Product Status 12

Heart Failure Risk Stratification Test-Product Description 12

Plasminogen Activator Inhibitor Type-1 Test-Product Status 13

Plasminogen Activator Inhibitor Type-1 Test-Product Description 13

QL Care Analyzer-Product Status 14

QL Care Analyzer-Product Description 14

Troponin-I Test-Product Status 15

Troponin-I Test-Product Description 15

CardioGenics Inc, Key Employees 17

Glossary 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

CardioGenics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 50588
Site License
USD 1500 INR 101175
Corporate User License
USD 2250 INR 151763

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com